CN103190625A - Seabuckthorn phyllanthus chrysanthemum composite concentrated solution diet therapy product for regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply - Google Patents
Seabuckthorn phyllanthus chrysanthemum composite concentrated solution diet therapy product for regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply Download PDFInfo
- Publication number
- CN103190625A CN103190625A CN2013101295068A CN201310129506A CN103190625A CN 103190625 A CN103190625 A CN 103190625A CN 2013101295068 A CN2013101295068 A CN 2013101295068A CN 201310129506 A CN201310129506 A CN 201310129506A CN 103190625 A CN103190625 A CN 103190625A
- Authority
- CN
- China
- Prior art keywords
- blood
- milliliters
- chrysanthemum
- seabuckthorn
- phyllanthus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a seabuckthorn phyllanthus chrysanthemum composite concentrated solution diet therapy product for regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply, and the product is developed for the elderly, those suffering from hyperlipemia, high blood viscosity, myocardial ischemia, and those who are sub-healthy in blood lipid, blood viscosity and heart and cerebral vessels. With seabuckthorn as the main component, which is mixed with phyllanthus extracting solution and chrysanthemum extracting solution, and the components are compatible to prepare the seabuckthorn phyllanthus chrysanthemum composite concentrated solution, which has the functions of repairing and protecting vascular endothelial cells, regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply, and effectively intervening blood and blood vessel sub-healthy state. The product is used for diet therapy treatment of the elderly, those suffering from hyperlipemia, high blood viscosity, myocardial ischemia, and those who are sub-healthy in blood lipid, blood viscosity and heart and cerebral vessels, prevents aggravation of the blood and blood vessel sub-healthy state of the people, and prevents the occurrence and development of cardia-cerebrovascular diseases.
Description
Technical field:
The present invention relates to human body restoration and protection vascular endothelial cell; regulate blood fat and fall the sticking and increase myocardial blood supply function of blood, develop medicine-food two-purpose kind fresh syrup of Fructrs Hippophae, emblic extract and chrysanthemum extract liquid composition of prescription specially for it and make " the compound concentrate of husky surplus chrysanthemum " dietary product.
Background technology:
Cardiovascular and cerebrovascular disease is common clinical, frequently-occurring disease, and national health in serious threat.According to statistics, China cardiovascular and cerebrovascular patient has reached 200,000,000, and patient crowd by shifting to a middle-aged person more than 50 years old, dies from the cardiovascular and cerebrovascular diseases number every year and reaches more than 3,500,000.Cardiovascular and cerebrovascular diseases have incidence of disease height, disability rate height, death rate height and the high characteristics of recurrence rate, have become " the No.1 killer " of harm national health.Atherosclerotic is the main pathological basis of cardiovascular and cerebrovascular, reaches the control of " high blood glues disease " at its main hazard factor-" hyperlipidemia ", is the key of carrying out the cardiovascular and cerebrovascular diseases primary prevention.Though the Western medicine lipid lowerers is effective, toxic and side effects such as its digestive system and liver are obvious, and easily bounce-back makes to take for a long time to be restricted after the drug withdrawal.Blood fat health, these two accurate word medicines of selling as Chinese patent drug of Zhibituo, its active ingredient also is the Statins composition, many people take the phenomenon that hepatic injury also can appear in the blood fat health for a long time.The herbal species of other reducing blood lipid is many, but lipid-lowering effect is all not obvious.In addition, only emphasize the publicity of reducing blood lipid in the society, and ignore the importance that reduces blood viscosity, increases the myocardial blood supply function.Studies show that the elderly has often increased the incidence of disease of cardiovascular and cerebrovascular diseases because of blood viscousness, caused cardiovascular and cerebrovascular diseases because of the myocardial blood supply miopragia.
Motherland's medical science " dietotherapy ", development is the history of existing more than one thousand years so far.How on the basis of inheriting ancestor's " dietotherapy ", " dietary product " quality-improving to the level that can effectively intervene the cardiovascular and cerebrovascular sub-health state, being applied among the primary prevention secondary prevention of cardiovascular and cerebrovascular diseases, is a very thorny thing.This " dietary product " will make the emphasis reach of intervening cardiovascular and cerebrovascular diseases, accomplish real prophylactic the development, and this is more effective, safer than the treatment after ill, science more.
Fresh syrup of Fructrs Hippophae, emblic extract and chrysanthemum extract liquid composition of prescription are made the restoration and protection vascular endothelial cell, the adjusting blood fat falls blood " the compound concentrate of husky surplus chrysanthemum " dietary product sticking and the increase myocardial blood supply and still belongs to blank.
Goal of the invention:
Purpose of the present invention is to provide a kind of restoration and protection vascular endothelial cell, adjusting blood fat to fall the sticking dietary product that increases myocardial blood supply that reaches of blood, and preparation method thereof.
Technical scheme of the present invention is as follows:
The sticking dietary product that increases myocardial blood supply that reaches of blood falls in a kind of restoration and protection vascular endothelial cell, adjusting blood fat; it is characterized in that: by 300 milliliters-800 milliliters of fresh syrup of Fructrs Hippophae; 100 milliliters-600 milliliters of emblic extracts; 100 milliliters-600 milliliters of chrysanthemum extract liquids, steviol glycoside (sweetener) 0.2 gram-3 grams.Make 1000 milliliters of compound concentrates of the surplus chrysanthemum of sand, can is in 50 milliliters of vials.
Fresh syrup of Fructrs Hippophae: the fruit juice that gets through squeezing for sea-buchthorn fresh fruit.1962, Qinghai Province Department of Public Health was written into Qinghai Province's drug standards with fresh syrup of Fructrs Hippophae, and its function is expressed as " clearing and antitussive, promoting blood circulation and removing blood stasis, ulcer heals ".Modern Biochemical Research and pharmacological experiment confirm to contain in the fresh syrup of Fructrs Hippophae multivitamin, several amino acids, multiple organic acid, flavone compound, polyphenol compound, phytosterin compound, terpenoid, various trace elements, pulp oil and other active component.Have and strengthen immunity, anti-oxidant, anti-sudden change, antitumor, restoration and protection vascular endothelial cell, reduce blood fat, reduce blood viscosity, reduce myocardial oxygen consumption, increase myocardial blood supply, strengthen dietary function widely such as cardiac function, radioresistance, antifatigue, reduction blood sugar.Fresh syrup of Fructrs Hippophae energy restoration and protection vascular endothelial cell, reduction blood fat blood glue, increase the very worth more deep research of the mechanism of action of myocardial blood supply.
The emblic extract: emblic is the medicine-food two-purpose kind, is a kind of Tibetan medicine commonly used.Be written into that " Chinese pharmacopoeia in the Tibetan medicine, has 59 kinds to contain emblic in the Sanitation Ministry medicine standard nineteen ninety-five version Tibetan medicine standard contained 200, accounts for 29% in 1977.Modern Biochemical Research shows that emblic is rich in multivitamin, several amino acids, multiple unrighted acid, polyphenol compound, flavone compound, terpenoid, phytosterin compound, glycosides compound, alkaloid and various trace elements isoreactivity composition.In Tibetan medicine, emblic cures mainly Baconic's disease, red bar disease, blood disease, high blood pressure etc.In recent years pharmacological experiments shows, emblic has anti-inflammatory, anti-oxidant, anti-ageing, immunological regulation, reducing blood lipid, fall that blood is sticking, antiatherosclerosis, antiulcer, protect the liver and block pharmacological action widely such as poisonous metal harm.
Chrysanthemum extract liquid: chrysanthemum is the medicine-food two-purpose kind.In Shennong's Herbal, chrysanthemum is classified as product on the medicine, think " obey sharp vim and vigour for a long time, make light of one's life by commiting suicide anti-prolong life always ".Modern Biochemical Research shows that the main component of chrysanthemum is that the content of volatile oil, flavone compound, several amino acids, triterpene compound, phytosterin compound, chlorogenic acid and various trace elements, particularly manganese, zinc, selenium is higher.Modern pharmacology studies confirm that, pharmacological action widely such as the chrysanthemum active component has coronary artery dilator, resists myocardial ischemia, brings high blood pressure down, anti-arrhythmia, reducing blood lipid, anti-sudden change, antitumor, antimicrobial antiphlogistic, antiviral, immunological regulation, lead discharging.
The compatibility explanation:
Product safety, effective, quality controllable be the most basic requirement of dietary product.Fresh syrup of Fructrs Hippophae is that the squeezing of medicine-food two-purpose kind sea-buchthorn fresh fruit makes, and the emblic extract is that medicine-food two-purpose kind emblic makes with the pure water extraction, and chrysanthemum extract liquid is that the medicine-food two-purpose breed chrysanthemum makes with the pure water extraction.Product of the present invention with the general flavone in the fresh syrup of Fructrs Hippophae, organic acid, delphinidin glycoside etc. be main restoration and protection vascular endothelial cell, regulating blood fat, to fall blood sticking and increase the active component of myocardial blood supply, Chrysan Yellow ketonic compound, polyphenol compound isoreactivity composition in the composite emblic extract of prescription in flavone compound, terpenoid, phytosterin compound, glycosides compound etc. and the chrysanthemum extract liquid play joint action of potentiation equally.
Its processing method is:
Purify the drink workshop at 100,000 grades, fresh syrup of Fructrs Hippophae in the prescription, emblic extract, chrysanthemum extract liquid, steviol glycoside are added in the blending tank and mix, to mix uniform material and carry out homogeneous, material behind the homogeneous is pumped into the gravity tank of bottle placer, with material can vial, capping, lamp inspection, sterilization, quality inspection, packing.Stand-by.
Useful result of the present invention:
Take 50 milliliters " the compound concentrates of husky surplus chrysanthemum " 2 bottles every day; can obtain total seabuckthorn flavone, polyphenol compound, the oside compound of capacity dietary function; emblic flavone compound, phenolic acid compound; chrysanthemum flavones and polyphenol compound isoreactivity composition have the restoration and protection vascular endothelial cell, regulating blood fat, to fall blood sticking and increase the effect of myocardial blood supply.Can be used for the sticking crowd of the elderly, high fat of blood, high blood, blood fat blood is sticking and blood vessel sub-health state crowd dietotherapy treatment, effectively intervenes and reverses blood blood vessel sub-health state, the generation of prevention cardiovascular and cerebrovascular diseases increases the weight of with the prevention cardiovascular and cerebrovascular diseases.
The specific embodiment:
Embodiment 1: get 175 liters of fresh syrup of Fructrs Hippophae, 45 liters of emblic extracts, 30 liters of chrysanthemum extract liquids, steviol glycoside 75 grams.Purify the drink workshop at 100,000 grades, with 175 liters of the fresh syrup of Fructrs Hippophae in the above-mentioned prescription, 45 liters of emblic extracts, 30 liters of chrysanthemum extract liquids, steviol glycoside 75 grams add in the material blending tank and mixed 20 minutes, to pump into the gravity tank of bottle placer behind the material homogeneous that mix again, 50 milliliters of vials of can, its theoretical yield is 5000 bottles.Lamp inspection, sterilization, quality inspection, packing.Stand-by.Make dietary product " the compound concentrate of husky surplus chrysanthemum ".
Embodiment 2: get 105 liters of fresh syrup of Fructrs Hippophae, 24 liters of emblic extracts, 21 liters of chrysanthemum extract liquids, steviol glycoside 30 grams.Purify the drink workshop at 100,000 grades, with 105 liters of the fresh syrup of Fructrs Hippophae in the above-mentioned prescription, 24 liters of emblic extracts, 21 liters of chrysanthemum extract liquids, steviol glycoside 30 grams add in the material blending tank and mixed 20 minutes, to pump into the gravity tank of bottle placer behind the material homogeneous that mix again, 100 milliliters of vials of can, its theoretical yield is 1500 bottles.Lamp inspection, sterilization, quality inspection, packing.Stand-by.Make dietary product " the compound concentrate of husky surplus chrysanthemum ".
Active ingredient and content:
Every 100ml contains total seabuckthorn flavone (rutin meter) 〉=55mg
Emblic chrysanthemum total flavone (rutin meter) 〉=110mg
Chlorogenic acid>10mg
The optimum crowd:
The sticking unusual person of the elderly, blood fat and blood, myocardial ischemia, the low person of heart function
Using method and consumption
One after each meal, each 50 milliliters, can dilute and take at every day twice
Description of drawings:
Accompanying drawing is process diagram of the present invention.
Claims (3)
1. regulate blood fat to fall blood sticking and increase " the compound concentrate of husky surplus chrysanthemum " dietary product of myocardial blood supply for one kind, it is characterized in that: by 300 milliliters-800 milliliters of fresh syrup of Fructrs Hippophae, 100 milliliters-600 milliliters of emblic extracts, 100 milliliters-600 milliliters of chrysanthemum extract liquids, steviol glycoside (sweetener) 0.2 gram-3 grams.Make 1000 milliliters " the compound concentrates of husky surplus chrysanthemum ", can is in 50 milliliters of vials.
2. a kind ofly regulate blood fat to fall blood sticking and increase " the compound concentrate of husky surplus chrysanthemum " dietary product of myocardial blood supply by claim 1 is described, it is characterized in that: can in 20 milliliters, 30 milliliters, so that in 200 milliliters of vials or the normal temperature sterile filling in 10 milliliters, 20 milliliters, so that in 50 milliliters of oral liquid plastic bottles.
3. by claim 1 and 2 described a kind of blood fat of regulating sticking " the compound concentrate of the husky surplus chrysanthemum " dietary product that increases myocardial blood supply that reaches of blood falls, it is characterized in that: emblic extracts concentrate, chrysanthemum extracts concentrate and adopts the pure water extraction to make, or the edible ethanol extraction makes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101295068A CN103190625A (en) | 2013-04-16 | 2013-04-16 | Seabuckthorn phyllanthus chrysanthemum composite concentrated solution diet therapy product for regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101295068A CN103190625A (en) | 2013-04-16 | 2013-04-16 | Seabuckthorn phyllanthus chrysanthemum composite concentrated solution diet therapy product for regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103190625A true CN103190625A (en) | 2013-07-10 |
Family
ID=48713591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101295068A Pending CN103190625A (en) | 2013-04-16 | 2013-04-16 | Seabuckthorn phyllanthus chrysanthemum composite concentrated solution diet therapy product for regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103190625A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107969504A (en) * | 2017-11-24 | 2018-05-01 | 恭城福茂生油茶文化产业发展有限公司 | A kind of processing method of bean curd stick |
CN113244367A (en) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | Medicated diet for people with hyperlipidemia |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010091416A (en) * | 2000-03-15 | 2001-10-23 | 이규환 | A marking method of health-help food, medical composite and special-nutritious food for improve the corpulence and the food |
CN101703134A (en) * | 2009-12-07 | 2010-05-12 | 刘惠娟 | Health protection tea |
CN102772466A (en) * | 2012-08-29 | 2012-11-14 | 苏州大学 | Application of chrysanthemum extract |
CN102972763A (en) * | 2012-12-05 | 2013-03-20 | 袁辉 | Preparation method of granules with effects of reducing blood pressure and blood fat |
-
2013
- 2013-04-16 CN CN2013101295068A patent/CN103190625A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010091416A (en) * | 2000-03-15 | 2001-10-23 | 이규환 | A marking method of health-help food, medical composite and special-nutritious food for improve the corpulence and the food |
CN101703134A (en) * | 2009-12-07 | 2010-05-12 | 刘惠娟 | Health protection tea |
CN102772466A (en) * | 2012-08-29 | 2012-11-14 | 苏州大学 | Application of chrysanthemum extract |
CN102972763A (en) * | 2012-12-05 | 2013-03-20 | 袁辉 | Preparation method of granules with effects of reducing blood pressure and blood fat |
Non-Patent Citations (1)
Title |
---|
潘道东: "《功能性食品添加剂》", 31 January 2006 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107969504A (en) * | 2017-11-24 | 2018-05-01 | 恭城福茂生油茶文化产业发展有限公司 | A kind of processing method of bean curd stick |
CN113244367A (en) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | Medicated diet for people with hyperlipidemia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mohamed et al. | Natural anti-obesity agents | |
CN101785552B (en) | Raspberry seed extractive and extraction process | |
Hosseini et al. | A comparison between the effect of green tea and Kombucha prepared from green tea on the weight of diabetic rats | |
Naeem et al. | Advancement and future directions towards herbal treatment for various diseases | |
Ağalar | Elderberry (Sambucus nigra L.) | |
Kalita | An overview on Mangifera indica: Importance and its various pharmacological action | |
CN103190625A (en) | Seabuckthorn phyllanthus chrysanthemum composite concentrated solution diet therapy product for regulating blood lipid, reducing blood viscosity, and increasing cardiac muscle blood supply | |
Brendler et al. | Devil’s Claw (Harpagophytum procumbens DC) an evidence-based systematic review by the natural standard research collaboration | |
DE202011105533U1 (en) | Vital substance composition according to Asian and Mediterranean nutritional concepts | |
CN109954008A (en) | A kind of sea buckthorn procyanidins soft capsule and preparation method for killing Eradication Therapy of Helicobacter pylori Infection gastric ulcer | |
Aversi-Ferreira et al. | Confrontation between ethnopharmacology and scientific results of the herbal medicaments from Brazil to be applied in primary health care | |
CN103566150A (en) | Medicine and food homologous food composition with blood fat reducing function as well as application thereof | |
CN102823866A (en) | Dietetic therapy product of sea-buckthorn lotus leaf juice for conditioning blood fat, reducing blood viscosity and improving myocardial blood | |
CN105267304A (en) | Anticoagulant and anti-platelet aggregation Shaji composition and preparation method | |
CN104491339A (en) | Seabuckthorn leaf composition for preventing and treating hyperlipidaemia and resisting thrombus and preparation method thereof | |
CN101485454A (en) | Chinese paris rhizome wine | |
Ali et al. | Determination of proximate, phytochemicals and minerals composition of vernonia amygdalina (bitter leaf) | |
CN105519743A (en) | Health tea containing Chinese herbal medicines with functions of tonifying qi, replenishing blood, maintaining beauty and resisting fatigue and ageing | |
CN104997018A (en) | Yew enzyme health-care product as well as preparation method and application thereof | |
Mahato et al. | CITRUS WASTE REUSE FOR HEALTH BENEFITS AND PHARMA-/NEUTRACEUTICAL APPLICATIONS. | |
CN1611232A (en) | Medicinal composition with main effect of antifatigue, radioresistance and melancholia-resistance and its preparing method | |
CN102132919B (en) | Anti-fatigue and immunity-regulating drink and preparation method thereof | |
Muti et al. | Extract of Caesalpinia sappan L. heartwood as food treatment anti-diabetic: A narrative review | |
CN103349277A (en) | Hippophae rhamnoides, Phyllanthus emblica and chrysanthemum concentrate for effectively reducing lipoproteins (a) in blood plasma | |
KR101930145B1 (en) | Fasting supplement composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130710 |